对比增强乳腺X线摄影(CEM)评估乳腺X线摄影不对称的診断准确性:系统综述与Meta分析
该系统综述与Meta分析纳入7项研究、1266名女性、1328处不对称,评估CEM以组织病理学或长期随访为参考标准诊断恶性病变的准确性;汇总敏感度97%(95%CI 87-99)、特异度80%(95%CI 65-89)、AUC 0.96(95%CI 0.94-0.97),阳性似然比6.6、阴性似然比0.03,结论为CEM对不对称的评估具有高敏感度和极佳总体准确性,可用于排除恶性。
要点
- CEM评估乳腺X线摄影不对称的汇总敏感度为97%(95%CI 87-99),阴性似然比0.03。
- 汇总特异度为80%(95%CI 65-89),阳性似然比6.6,AUC 0.96(95%CI 0.94-0.97)。
- 作者认为CEM有助于排除恶性,并可能减少不必要的活检。
核心结论
- CEM在评估乳腺X线摄影不对称时表现出高敏感度和极佳的总体准确性,是排除恶性的有价值工具。
- 作者认为将其应用于临床实践有可能减少不必要的活检并优化诊断路径,尤其在MRI不可及的环境中可作为一种可及且有效的替代选择。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA-DTA指南。
- 检索PubMed、Embase和Web of Science截至2025年4月的文献,纳入以组织病理学或长期随访为参考标准、评估CEM用于乳腺不对称的研究。
- 共纳入7项研究,涉及1266名女性、1328处不对称。
- 采用双变量随机效应模型计算敏感度、特异度、似然比和总结ROC曲线下面积(AUC)的合并估计值。
诊断标准与关键数值
- CEM检测不对称中恶性的汇总敏感度为97%(95%CI 87-99)。
- 汇总特异度为80%(95%CI 65-89)。
- 合并阳性似然比为6.6,合并阴性似然比为0.03。
- 总体诊断准确性AUC为0.96(95%CI 0.94-0.97)。
临床应用与阅片要点
- 作者认为CEM可用于排除乳腺X线摄影不对称中的恶性。
- 作者认为在临床实践中应用CEM有可能减少不必要的活检并优化诊断路径。
- 作者认为在MRI不可及的环境中,CEM可作为一种可及且有效的替代选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Mammographic asymmetries present a significant diagnostic challenge, often leading to unnecessary biopsies due to the limitations of conventional imaging. Contrast-enhanced mammography (CEM) has emerged as a promising modality that combines anatomical detail with functional information on tumor vascularity. However, its specific role and accuracy in evaluating asymmetries have not been systematically synthesized. This meta-analysis aims to determine the diagnostic accuracy of CEM for classifying mammographic asymmetries and its potential to reduce unnecessary interventions.
METHOD: A systematic review and meta-analysis was conducted following PRISMA-DTA guidelines. The PubMed, Embase, and Web of Science databases were searched for studies published up to April 2025 that evaluated CEM for breast asymmetries using histopathology or long-term follow-up as the reference standard. A bivariate random-effects model was employed to calculate pooled estimates of sensitivity, specificity, likelihood ratios, and the area under the summary ROC curve (AUC).
RESULTS: Seven studies involving 1,266 women with 1,328 asymmetries met the inclusion criteria. The pooled analysis showed that CEM has a high sensitivity of 97% (95% CI: 87-99) and a specificity of 80% (95% CI: 65-89) for detecting malignancy in asymmetries. The combined positive and negative likelihood ratios were 6.6 and 0.03, respectively. The overall diagnostic accuracy was excellent, with an AUC of 0.96 (95% CI: 0.94-0.97).
CONCLUSION: CEM demonstrates high sensitivity and excellent overall accuracy in the evaluation of mammographic asymmetries, making it a valuable tool for ruling out malignancy. Its implementation in clinical practice has the potential to reduce unnecessary biopsies and optimize diagnostic pathways, offering an accessible and effective alternative, particularly in settings where MRI is unavailable.
引用
- Barra FR, Ohannesian VA, Andrade Fernandes JV, et al. Diagnostic accuracy of contrast-enhanced mammography (CEM) for the evaluation of mammographic asymmetries: A systematic review and meta-analysis. Eur J Radiol. 2026. PMID: 41861612. doi:10.1016/j.ejrad.2026.112806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。